E. Bien-que-tous-les and . Graves-ou-non, connus ou non, doivent être déclarés depuis 2011, l'apport des déclarations est bien sûr plus important pour les déclarations des EI non connus et/ou graves. L'incidence des EI non connus et/ou graves ne nous aurait pas permis d'évaluer l'adhésion des patients à cette procédure de déclaration

. Dans-notre-Étude, on notait 38 % d'EI graves et 22,2 % d'EI non mentionnés dans le RCP. En médecine générale, Moride et al (13)

L. Hazell and S. Shakir, Under-Reporting of Adverse Drug Reactions, Drug Safety, vol.29, issue.1, pp.385-96, 2006.
DOI : 10.2165/00002018-200629050-00003

. Rôle-des-différents-acteurs-ansm, Agence nationale de sécurité du médicament et des produits de santé [En ligne]. [consulté le 28 Disponible sur: http://ansm.sante.fr/Declarer-un-effet-indesirable/Pharmacovigilance/Role-desdifferents-acteurs, 2016.

. Votre-déclaration-concerne-un-médicament-ansm, Agence nationale de sécurité du médicament et des produits de santé [En ligne]. [consulté le 28 Disponible sur: http://ansm.sante.fr/Declarer-un-effet-indesirable/Votre-declaration-concerne-unmedicament/Votre-declaration-concerne-un-medicament, 2016.

Y. Arimone, I. Bidault, J. Dutertre, M. Gérardin, C. Guy et al., R??actualisation de la m??thode fran??aise d???imputabilit?? des effets ind??sirables des m??dicaments, Th??rapie, vol.66, issue.6, pp.517-542, 2011.
DOI : 10.2515/therapie/2011073

J. Blayac, F. Haramburu, S. Lerebours, and T. Vial, Information du prescripteur et aide à la prescription: rôle des centres régionaux de pharmacovigilance, Presse Med, vol.29, issue.2, p.115, 2008.

. Commission-européenne and . Europa-, Agence européenne des médicaments (EMA) [En ligne]. European Union website, the official EU website -European Commission, Disponible sur, 2016.

T. Vial, Pharmacovigilance fran??aise??: missions, organisation et perspectives, Th??rapie, vol.71, issue.2, pp.135-177, 2016.
DOI : 10.1016/j.therap.2016.02.028

Y. Moride, F. Haramburu, A. Requejo, and B. Bégaud, Under-reporting of adverse drug reactions in general practice, British Journal of Clinical Pharmacology, vol.43, issue.2, pp.177-81, 1997.
DOI : 10.1046/j.1365-2125.1997.05417.x

J. Grange, Un an de recueil prospectif syst??matique et d???analyse des effets ind??sirables dus aux m??dicaments, aux dispositifs m??dicaux ou aux proc??dures en m??decine g??n??rale, Th??rapie, vol.67, issue.3, pp.237-279, 2012.
DOI : 10.2515/therapie/2012028

C. Lacoste-roussillon, P. Pouyanne, F. Haramburu, G. Miremont, and B. Bégaud, Incidence of serious adverse drug reactions in general practice: A prospective study, Clinical Pharmacology & Therapeutics, vol.69, issue.6, pp.458-62, 2001.
DOI : 10.1067/mcp.2001.116145

D. Giet, Ecologie des soins médicaux, carré de White, soins primaires et médecine générale, Rev Med Liege, vol.61, pp.5-6277, 2006.

E. Lopez-gonzalez, M. Herdeiro, and A. Figueiras, Determinants of Under-Reporting of Adverse Drug Reactions, Drug Safety, vol.31, issue.4, pp.19-31, 2009.
DOI : 10.2165/00002018-200932010-00002

A. Cox, C. Anton, S. Mcdowell, J. Marriott, and R. Ferner, The Paradox of Low Prescribers who are High??Reporters: Correlates of Spontaneous Reporting??of??Adverse Drug Reactions within Primary Care, Drug Safety, vol.30, issue.10, pp.529-563, 2010.
DOI : 10.2165/00002018-200730100-00160

J. Hasford, M. Goettler, K. Munter, and B. Müller-oerlinghausen, Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions, Journal of Clinical Epidemiology, vol.55, issue.9, pp.945-50, 2002.
DOI : 10.1016/S0895-4356(02)00450-X

F. Haramburu, B. Bégaud, and Y. Moride, Temporal trends in spontaneous reporting of unlabelled adverse drug reactions, British Journal of Clinical Pharmacology, vol.44, issue.3, pp.299-301, 1997.
DOI : 10.1046/j.1365-2125.1997.t01-1-00573.x

A. Pariente, F. Grégoire, A. Fourrier-réglat, F. Haramburu, and N. Moore, Impact of Safety Alerts on Measures of Disproportionality in Spontaneous Reporting Databases, Drug Safety, vol.4, issue.4, pp.891-899, 2007.
DOI : 10.2165/00002018-200730100-00007

L. Vogel and T. Sysak, Physicians should be paid to report adverse drug reactions, experts say, Canadian Medical Association Journal, vol.184, issue.8, pp.409-419
DOI : 10.1503/cmaj.109-4153

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348215

J. Hartley, Pay doctors to report adverse events [En ligne] Australian Doctor. 2013 [consulté le 28, Disponible sur, 2016.

J. Feely, S. Moriarty, O. Connor, and P. , Stimulating reporting of adverse drug reactions by using a fee., BMJ, vol.300, issue.6716, pp.22-25, 1990.
DOI : 10.1136/bmj.300.6716.22

M. Bäckström and T. Mjörndal, A small economic inducement to stimulate increased reporting of adverse drug reactions???a way of dealing with an old problem?, European Journal of Clinical Pharmacology, vol.11, issue.37, pp.381-386, 2006.
DOI : 10.1007/s00228-005-0072-0

A. Maladie, La rémunération sur objectifs de santé publique: une amélioration continue en faveur de la qualité et de la pertinence des soins Bilan à 3 ans

J. Castel, A. Figueras, C. Pedrós, J. Laporte, and D. Capellà, Stimulating Adverse Drug Reaction Reporting, Drug Safety, vol.43, issue.14, pp.1049-55, 2003.
DOI : 10.2165/00002018-200326140-00005

C. Biagi, N. Montanaro, E. Buccellato, G. Roberto, A. Vaccheri et al., Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia???Romagna region), European Journal of Clinical Pharmacology, vol.296, issue.2, pp.237-281, 2013.
DOI : 10.1007/s00228-012-1321-7

M. Johansson, G. Brunlöf, C. Edward, and S. Wallerstedt, Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports, European Journal of Clinical Pharmacology, vol.7, issue.5
DOI : 10.1007/s00228-008-0603-6

URL : https://hal.archives-ouvertes.fr/hal-00534937

M. Johansson, S. Hägg, and S. Wallerstedt, Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study, BMC Clinical Pharmacology, vol.58, issue.7, p.14, 2011.
DOI : 10.1007/s00228-002-0484-z

. Abonnement-ansm, Agence nationale de sécurité du médicament et des produits de santé [En ligne]. [consulté le 28, Disponible sur, p.2, 2016.

S. Wallerstedt, G. Brunlöf, M. Johansson, C. Tukukino, and L. Ny, Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor, European Journal of Clinical Pharmacology, vol.62, issue.5, pp.505-513, 2007.
DOI : 10.1007/s00228-007-0270-z

I. Oosterhuis, F. Van-hunsel, and E. Van-puijenbroek, Expectations for Feedback in Adverse Drug Reporting by Healthcare Professionals in the Netherlands, Drug Safety, vol.81, issue.2, pp.221-253, 2012.
DOI : 10.2165/11594910-000000000-00000

A. Passier, M. Ten-napel, K. Van-grootheest, and E. Van-puijenbroek, Reporting of Adverse Drug Reactions by General Practitioners, Drug Safety, vol.55, issue.8, pp.851-859, 2009.
DOI : 10.2165/11314490-000000000-00000

C. Rosebraugh, Y. Tsong, F. Zhou, M. Chen, A. Mackey et al., Improving the quality of adverse drug reaction reporting by 4th-year medical students, Pharmacoepidemiology and Drug Safety, vol.30, issue.2, pp.97-101, 2003.
DOI : 10.1002/pds.797

M. Tabali, E. Jeschke, A. Bockelbrink, C. Witt, S. Willich et al., Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine, BMC Public Health, vol.31, issue.1, p.274, 2009.
DOI : 10.2165/00002018-200831040-00007

E. Lopez-gonzalez, M. Herdeiro, M. Piñeiro-lamas, and A. Figueiras, Effect of An Educational Intervention to Improve Adverse Drug Reaction Reporting in Physicians: A Cluster Randomized Controlled Trial, Drug Safety, vol.34, issue.9, pp.189-96, 2015.
DOI : 10.1007/s40264-014-0256-6

M. Herdeiro, I. Ribeiro-vaz, M. Ferreira, J. Polónia, A. Falcão et al., Workshop- and Telephone-Based Interventions to Improve Adverse Drug Reaction Reporting, Drug Safety, vol.45, issue.1, pp.655-65, 2012.
DOI : 10.1007/BF03261962

M. Molokhia, T. S. Bell, and D. , Improving reporting of adverse drug reactions: Systematic review, Clinical Epidemiology, vol.1, pp.75-92, 2009.
DOI : 10.2147/CLEP.S4775

F. Margraff and D. Bertram, Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries, Drug Safety, vol.33, issue.8, pp.409-428, 2014.
DOI : 10.1007/s40264-014-0162-y

A. Blenkinsopp, P. Wilkie, M. Wang, and P. Routledge, Patient reporting of suspected adverse drug reactions: a review of published literature and international experience, British Journal of Clinical Pharmacology, vol.182, issue.2, pp.148-56, 2007.
DOI : 10.1016/S1090-3801(02)00114-3

C. Matos, L. Härmark, and F. Van-hunsel, Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities??? Views and Needs, Drug Safety, vol.13, issue.Suppl. 1, pp.1105-1116, 2016.
DOI : 10.1007/s40264-016-0441-x

N. Deleau, Expériences des signalements des effets indésirables par les patients [En ligne] Assises du médicament, Disponible sur, 2011.

D. Nasrallah-irles, A. Castot, L. Thomas, S. Babai, B. Delorme et al., Signalement d?????v??nements ind??sirables par les patients : ??tude pilote r??alis??e avec la collaboration d???associations de patients, Th??rapie, vol.63, issue.5, pp.385-92, 2008.
DOI : 10.2515/therapie:2008060

G. Durrieu, A. Palmaro, L. Pourcel, C. Caillet, A. Faucher et al., First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines, Drug Safety, vol.31, issue.6, pp.845-54, 2012.
DOI : 10.1007/BF03261980

J. Inch, M. Watson, and S. Anakwe-umeh, Patient versus Healthcare Professional Spontaneous Adverse Drug Reaction Reporting, Drug Safety, vol.33, issue.462, pp.807-825, 2012.
DOI : 10.1007/BF03261977

L. Hazell, P. Hannaford, S. Shakir, and A. Avery, How Do Patients Contribute to Signal Detection?, Drug Safety, vol.20, issue.3, pp.199-206, 2013.
DOI : 10.1007/s40264-013-0021-2

J. De-langen, F. Van-hunsel, A. Passier, L. De-jong-van-den-berg, and K. Van-grootheest, Adverse Drug Reaction Reporting by Patients in the Netherlands, Drug Safety, vol.128, issue.2, pp.515-539, 2008.
DOI : 10.2165/00002018-200831060-00006

D. Mclernon, C. Bond, P. Hannaford, M. Watson, A. Lee et al., Adverse Drug Reaction Reporting in the UK, Drug Safety, vol.98, issue.2, pp.775-88, 2010.
DOI : 10.2165/11536510-000000000-00000

A. Avery, C. Anderson, C. Bond, H. Fortnum, A. Gifford et al., Evaluation of patient reporting of adverse drug reactions to the UK ???Yellow Card Scheme???: literature review, descriptive and qualitative analyses, and questionnaire surveys, Health Technology Assessment, vol.15, issue.20, pp.1-234, 2011.
DOI : 10.3310/hta15200

L. Aagaard and E. Hansen, Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011, BMC Pharmacology and Toxicology, vol.83, issue.1, p.30, 2007.
DOI : 10.1503/cmaj.110218

L. Härmark, F. Van-hunsel, and B. Grundmark, ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems, Drug Safety, vol.36, issue.12, pp.337-384, 2015.
DOI : 10.1007/s40264-015-0264-1

L. Aagaard, L. Nielsen, and E. Hansen, Consumer Reporting of Adverse Drug Reactions, Drug Safety, vol.54, issue.11, pp.1067-74, 2004.
DOI : 10.2165/11316680-000000000-00000

K. Fjermeros, M. Werner, P. Harg, H. Samdal, L. Slørdal et al., Patient reporting of adverse drug reactions in Norway 2010-13. Tidsskr Den Nor Laegeforen Tidsskr Prakt Med Ny Raekke, pp.536-576, 2015.

A. Vilhelmsson, T. Svensson, A. Meeuwisse, and A. Carlsten, Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association, BMC Pharmacology and Toxicology, vol.10, issue.2, p.19, 2012.
DOI : 10.1186/1472-6904-10-16

D. Health and M. Authority, Adverse drug reaction reported by consumers in Denmark ? compared with reports from healthcare professionals, Disponible sur, 2013.

. Ancel, P. Santos, and . Advisor, Health Action International Direct Patient Reporting in the European Union A Snapshot of Reporting Systems in Seven Member States [En ligne]. [consulté le 17, 2015.

J. Vallée, B. Trombert-paviot, A. Passier, E. Van-puijenbroek, and K. Van-grootheest, Information des patients sur les effets indésirables des médicaments Disponible sur: http://www.jle.com/download/med-303752- information_des_patients_sur_les_effets_indesirables_des_medicaments-- V@5ku38AAQEAADsKPo8AAAAN-a.pdf 60 Motives for reporting adverse drug reactions by patient-reporters in the Netherlands, J Pharm Clin Eur J Clin Pharmacol, vol.303466, issue.111, pp.20151143-50, 2010.

L. Härmark, M. Lie-kwie, L. Berm, H. De-gier, and K. Van-grootheest, Patients??? motives for participating in active post-marketing surveillance, Pharmacoepidemiology and Drug Safety, vol.63, issue.2, pp.70-76, 2013.
DOI : 10.1002/pds.3327

C. Anderson, J. Krska, E. Murphy, and A. Avery, The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective, British Journal of Clinical Pharmacology, vol.30, issue.5, pp.806-828, 2011.
DOI : 10.1111/j.1365-2125.2011.03990.x

D. Mclernon, C. Bond, A. Lee, M. Watson, P. Hannaford et al., Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK, Pharmacoepidemiology and Drug Safety, vol.3, issue.2, pp.523-554, 2011.
DOI : 10.1002/pds.2117

Y. Zopf, C. Rabe, A. Neubert, K. Gassmann, W. Rascher et al., Women encounter ADRs more often than do men, European Journal of Clinical Pharmacology, vol.18, issue.5, pp.999-1004, 2008.
DOI : 10.1007/s00228-008-0494-6

C. Matos, F. Van-hunsel, and J. Joaquim, Are consumers ready to take part in the Pharmacovigilance System????a Portuguese preliminary study concerning ADR reporting, European Journal of Clinical Pharmacology, vol.329, issue.7465
DOI : 10.1007/s00228-015-1867-2

E. Parretta, C. Rafaniello, L. Magro, C. Pittoni, A. Sportiello et al., Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy, Expert Opinion on Drug Safety, vol.59, issue.sup1, pp.21-30, 2014.
DOI : 10.2165/00002018-200831060-00006

R. Leone, U. Moretti, D. Incau, P. Conforti, A. Magro et al., Effect of Pharmacist Involvement on Patient Reporting of Adverse Drug Reactions: First Italian Study, Drug Safety, vol.35, issue.3, pp.267-76, 2013.
DOI : 10.1007/s40264-013-0028-8

M. Gahr, J. Eller, B. Connemann, and C. Schönfeldt-lecuona, Subjective Reasons for Non-Reporting of Adverse Drug Reactions in a Sample of Physicians in Outpatient Care, Pharmacopsychiatry, vol.49, issue.02, pp.57-61, 2016.
DOI : 10.1055/s-0035-1569291

L. Bulcourt, Déclaration des effets indésirables médicamenteux chez les médecins généralistes: pour quoi ?, 2014.

J. Chouilly, Peut-on optimiser le recueil et la déclaration de la iatrogénie en médecine ambulatoire compte tenu des contraintes de la pratique?: à partir d'une étude de 2380 cas de iatrogénie relevés par des médecins généralistes français [Thèse d'exercice, 2009.

B. Ferry, Exploitation systématique de la iatrogénie identifiée en Médecine Générale à des fins de Pharmacovigilance [Thèse d'exercice], 2015.

E. Kaner, C. Haighton, and B. Mcavoy, So much post, so busy with practice--so, no time! " : a telephone survey of general practitioners' reasons for not participating in postal questionnaire surveys, Br J Gen Pr, vol.48, issue.428, pp.1067-1076, 1998.

E. Morice and E. Leroyer, Existe-t-il des éléments prédictifs de l'implication des médecins généralistes dans les thèses de recherche en médecine générale? Exercer, pp.31-33, 2012.

I. Supper, R. Ecochard, C. Bois, F. Paumier, N. Bez et al., How do French GPs consider participating in primary care research: the DRIM study, Family Practice, vol.28, issue.2, pp.226-258, 2011.
DOI : 10.1093/fampra/cmq073

URL : https://hal.archives-ouvertes.fr/hal-00698243

H. Brodaty, L. Gibson, M. Waine, A. Shell, R. Lilian et al., Research in general practice: a survey of incentives and disincentives for research participation, Ment Health Fam Med, vol.10, issue.3, pp.163-73, 2013.

J. Rault, L. Breton-lerouvillois, and G. , La démographie médicale en Région Aquitaine: situation en 2015 Conseil National de l'Ordre des Médecins Disponible sur: http://demographie.medecin.fr/sites, p.2016